HealthSource Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: compounded GLP-1 (injection or oral), all 50 states, billed per 4-week supply
HealthSource scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
Price checked on HealthSource’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy. Starting from $199/month for semaglutide, each subscription covers the cost of medication, supplies, a telehealth visit with a board-certified physician, and unlimited provider messaging through a HIPAA-compliant platform. Services are available in all 50 US states with direct-to-door delivery in 3–5 business days.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to HealthSource
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $199/4 wks (billed per 4 weeks) · no insurance needed
HealthSource at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Tirzepatide
- Starting price
- $199/4 wks (billed per 4 weeks)
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored HealthSource
Each dimension is scored algorithmically from HealthSource’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
5.9/10At $199/mo (per 4 weeks), HealthSource runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
7.3/10HealthSource offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.9/10Online intake and platform experience (ongoing clinician messaging, consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.4/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.4/10HealthSource treats patients in all 50 states.
Support10%
5.5/10Clinician messaging between visits.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this HealthSource review
Last checked November 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$399/mo across 3 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with HealthSource
We walked HealthSource’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Place an order and answer a quick medical questionnaire.
- 2Complete an online telehealth visit with a physician (same-day consultations available).
- 3Prescription and medication ship within 3-5 business days with tracking.
- 4Ongoing support via a HIPAA-compliant platform and 24/7 care team access.
- Monthly pricing shown up front: Semaglutide from $199, Tirzepatide injection from $299, oral Tirzepatide from $399, each every 4 weeks.
- Medications ship from a US-based FDA 503A licensed partner pharmacy.
- Order is placed before the telehealth consultation occurs.
- A Refund & Returns link exists in the footer but terms were not shown.
- Support offered by phone, email, and portal messaging with 24/7 care-team access.
HealthSource customer support
- Phone
- 212-203-9428
GLP-1 medications HealthSource offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides HealthSource offers
Beyond GLP-1s, HealthSource also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
'From $199.00 every 4 weeks' for compounded semaglutide+B12 vials with supplies. An 8-week supply is $349, a 10-week supply $249, and a microdose option $169 a month.
Listed as 'From: $299.00 every 4 weeks.' Injectable tirzepatide is dispensed through a 503A partner pharmacy. Multiple dose tiers are available, and $299 is the entry-tier price.
Listed as 'From: $399.00 every 4 weeks.' The oral sublingual tirzepatide tablet is taken once daily before bed and ships in 5–10 business days. $399 is the entry-tier price.
Ready to get started?
Plans and promotions change often, so check HealthSource's current pricing and active discounts before you decide.
What we like
- Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
- 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
- Every program covers the cost of medication, supplies, and telehealth visits, with no separate pharmacy fee
- Subscription auto-refund if monthly reassessment is not completed
- Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping
Watch-outs
- No physician names or clinical leadership disclosed on public pages
- No LegitScript certification found
- 503A partner pharmacy not named, which is less transparent than providers that disclose their 503B pharmacy
- Labs not mentioned on any product page, so the baseline bloodwork protocol is unknown
- WooCommerce e-commerce storefront may feel more transactional than clinical
Is HealthSource worth it?
HealthSource built its program around one core idea: compounded GLP-1 (injection or oral), all 50 states, billed per 4-week supply. It runs $199/month (per 4 weeks). That is a qualified figure, not a plain month-to-month price, so we don't rank it against the category median; the cost section below says what it covers. Its standout is a needle-free oral option for people who would rather not inject.
It fills through a 503A pharmacy. It also offers round-the-clock messaging and is staffed by board-certified clinicians.
How much HealthSource costs
Compounded semaglutide runs $199/month (per 4 weeks) and compounded tirzepatide runs $299–$399/month depending on plan, the low end listed as “per 4 weeks”.
Because HealthSource's headline figure is listed as “per 4 weeks”, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare HealthSource with the month-to-month prices of the alternatives below instead.
Belle Health (about $199/month) is one of the closest alternatives to weigh HealthSource against.
Medications: what HealthSource prescribes
HealthSource prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
HealthSource's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who HealthSource is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- live anywhere in the US and want the certainty that your state is already covered.
- value being able to message a clinician between visits instead of waiting on the next scheduled one.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
HealthSource treats patients in all 50 states, and offers clinician messaging between visits; we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
HealthSource is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. To see HealthSource against the wider field, use the full list of semaglutide providers we rank; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
HealthSource scores highest on state availability and ease of access.
Ready to start with HealthSource?
From $199/4 wks (billed per 4 weeks). See current pricing and start your free consultation.
HealthSource might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare HealthSource vs…
HealthSource scores6.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
HealthSource vs Amazon One Medical
Amazon One Medical scores 8.5/10

HealthSource vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this HealthSource review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See HealthSource's current pricing
Plans from $199/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.